首页> 外文期刊>Strahlentherapie und Onkologie >Large mediastinal tumor mass as a prognostic factor in Hodgkin's lymphoma: Is the definition on the basis of a chest radiograph in the era of CT obsolete? [Groβer Mediastinaltumor als prognostischer Faktor bei Hodgkin-Lymphom: Ist die Definition auf Basis der Thoraxr?ntgenaufname im CT-Zeitalter überholt?]
【24h】

Large mediastinal tumor mass as a prognostic factor in Hodgkin's lymphoma: Is the definition on the basis of a chest radiograph in the era of CT obsolete? [Groβer Mediastinaltumor als prognostischer Faktor bei Hodgkin-Lymphom: Ist die Definition auf Basis der Thoraxr?ntgenaufname im CT-Zeitalter überholt?]

机译:大纵隔肿瘤肿块是霍奇金淋巴瘤的预后因素:在CT时代基于胸部X光片的定义是否过时?大纵隔肿瘤是霍奇金淋巴瘤的预后因素:基于胸部X线的定义在CT时代已经过时了吗?

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: The risk factor large mediastinal tumor mass is an internationally accepted unfavorable prognostic factor in the staging of Hodgkin's lymphoma (HL). The definition of this risk factor varies considerably between large cooperative study groups. The purpose of the present analysis was to determine to which degree data obtained from chest radiograph (CRX) give the same results as those from CT scans (CT). Methods: A total of 145 de novo HL patients in early unfavorable and advanced stages were included in this study. A total of 94 patients had a large mediastinal tumor mass according to the guidelines of the German Hodgkin Study Group (GHSG), while 51 had mediastinal lymph node involvement only. The size of mediastinal involvement and the thoracic diameter were measured on CRX and CT. Agreement between CRX and CT was determined by sensitivity and specificity analysis as well as descriptive statistics and correlations. Results: The correlation of the diameters on CRX with those of CT was 0.95 for the tumor size and 0.77 for the thoracic diameter. The diagnostic decisionlarge mediastinal mass or notcorrelated with 0.81 between CRX and CT and was identical in 90.3% of cases. The sensitivity was 0.87 and the specificity 0.96 for CRX, which is considered the current standard. Conclusion: The results show that there is a high agreement between the measurements of CRX and CT. Diagnosis of a large mediastinal mass disagreed in 10% of patients. Since the correct diagnosis of this risk factor is decisive for the adequate multimodal treatment choice, CRX should not be omitted.
机译:目的:巨大的纵隔肿瘤肿块是霍奇金淋巴瘤(HL)分期中国际公认的不利预后因素。在大型合作研究小组之间,此风险因素的定义差异很大。本分析的目的是确定从胸部X光片(CRX)获得的数据与从CT扫描(CT)获得的数据在何种程度上给出相同的结果。方法:本研究共纳入145例处于不良早期和晚期的从头HL患者。根据德国霍奇金研究小组(GHSG)的指南,总共94例患者有较大的纵隔肿瘤肿块,而51例仅累及了纵隔淋巴结。在CRX和CT上测量纵隔累及的大小和胸径。 CRX和CT之间的一致性是通过敏感性和特异性分析以及描述性统计和相关性确定的。结果:CRX的直径与CT的直径相关,肿瘤大小为0.95,胸腔直径为0.77。 CRX与CT之间的诊断决策为纵隔肿块较大或不相关,为0.81,在90.3%的病例中相同。 CRX的灵敏度为0.87,特异性为0.96,被认为是目前的标准。结论:结果表明,CRX和CT的测量值具有很高的一致性。 10%的患者对大纵隔肿块的诊断不同。由于对这一危险因素的正确诊断对于适当的多式联运治疗选择至关重要,因此不应省略CRX。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号